ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,355Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 680

$810K Total Retail Price of All Prescriptions

Rank: 131 out of 680

543 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 543 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 11,203 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 671 451 1 1
HYDROCODONE-ACETAMINOPHEN 488 315 S3 2 4
FUROSEMIDE 450 341 3 6
TRAMADOL HCL 426 284 4 18
METFORMIN HCL 403 259 5 8
NEXIUM 391 290 6 16
HYDROCHLOROTHIAZIDE 357 239 7 9
METOPROLOL TARTRATE 355 258 8 12
SIMVASTATIN 345 284 9 3
SINGULAIR 315 247 10 91
LISINOPRIL 295 160 11 5
CLOPIDOGREL 293 235 12 26
GLIPIZIDE XL 288 179 13 142
POTASSIUM CHLORIDE 280 204 14 14
GLIPIZIDE 263 182 15 63
PLAVIX 254 208 16 39
CARVEDILOL 254 203 16 23
OMEPRAZOLE 245 205 18 7
ATORVASTATIN CALCIUM 244 165 19 11
GABAPENTIN 223 145 20 15
AMITRIPTYLINE HCL 203 138 R 21 47
SERTRALINE HCL 179 126 22 28
SYNTHROID 163 139 23 38
CLONIDINE HCL 158 92 24 36
QUINAPRIL HCL 147 121 25 104
LIPITOR 142 93 26 68
CYCLOBENZAPRINE HCL 139 78 R 27 81
MONTELUKAST SODIUM 134 103 28 157
METOPROLOL SUCCINATE 127 105 29 13
DOXAZOSIN MESYLATE 127 104 29 73
LEVOTHYROXINE SODIUM 123 94 31 2
DIGOXIN 122 87 32 58
DONEPEZIL HCL 117 102 33 27
PREDNISONE 114 96 34 50
ZOLPIDEM TARTRATE 114 89 34 17
MECLIZINE HCL 112 80 36 103
NAMENDA 106 94 37 35
ACETAMINOPHEN-CODEINE 102 76 S3 38 175
ALENDRONATE SODIUM 101 88 39 32
TRIAMCINOLONE ACETONIDE 94 64 40 199
ADVAIR DISKUS 93 56 41 53
TRIAMTERENE-HCTZ 89 59 42 52
WARFARIN SODIUM 89 85 42 20
PREMARIN 87 57 R 44 105
MELOXICAM 87 53 44 24
PRAVASTATIN SODIUM 87 83 44 10
SPIRONOLACTONE 85 45 47 82
NOVOLIN 70-30 85 70 47 236
CELEBREX 84 72 49 90
LOVASTATIN 82 55 50 44
AZITHROMYCIN 80 52 51 42
LANTUS 76 64 52 49
ACTOS 75 45 53 114
GLIPIZIDE ER 74 69 54 108
SPIRIVA 71 70 55 70
CRESTOR 70 42 56 25
ISOSORBIDE MONONITRATE ER 69 59 57 59
CLONIDINE 68 31 58 284
PROAIR HFA 68 33 58 67
KLOR-CON 10 67 38 60 184
IBUPROFEN 66 38 61 126
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 31 62 37
FAMOTIDINE 61 29 63 89
METFORMIN HCL ER 61 52 63 54
HALOPERIDOL 57 57 65 193
NIFEDIPINE ER 57 33 65 75
NITROGLYCERIN PATCH 55 43 67 271
FLUTICASONE PROPIONATE 55 49 67 41
HYDROXYZINE PAMOATE 54 44 R 69 272
ENALAPRIL MALEATE 53 41 70 65
EXELON 53 53 70 112
BYSTOLIC 52 28 72 79
TRAZODONE HCL 52 42 72 48
TAMSULOSIN HCL 51 44 74 34
METOCLOPRAMIDE HCL 51 42 74 118
METHYLPREDNISOLONE 50 34 76 93
VOLTAREN 50 41 76 253
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.